The Inflation Reduction Act Discourages Vital R&D in Cancer and Additional Small Molecule Medicines

The Inflation Reduction Act Discourages Vital R&D in Cancer Medicines PDF cover image

New research from the Partnership for Health Analytics and Research (PHAR) demonstrates how price setting provisions in the IRA could have an acute impact on cancer medicines and other small molecule treatments.

The Inflation Reduction Act Discourages Vital R&D in Cancer Medicines PDF cover image

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.